Estradiol augments while progesterone inhibits arginine transport in human endothelial cells through modulation of cationic amino acid transporter-1

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 309, Issue 4, 2015, Pages R421-R427

  Bentur, Ohad S ^a   Schwartz, Doron ^a   Chernichovski, Tamara ^a   Ingbir, Merav ^a   Weinstein, Talia ^a   Chernin, Gil ^a   Schwartz, Idit F ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Endothelial function; Estrogen; Progesterone

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE 1; PROGESTERONE; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 3; PRKCA PROTEIN, HUMAN; PROTEIN KINASE C ALPHA; PROTEIN KINASE INHIBITOR; SLC7A1 PROTEIN, HUMAN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; MODULATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; AGONISTS; ANTAGONISTS AND INHIBITORS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; KINETICS; METABOLISM; PHOSPHORYLATION; TRANSPORT AT THE CELLULAR LEVEL;

ARGININE; BIOLOGICAL TRANSPORT; CATIONIC AMINO ACID TRANSPORTER 1; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROGESTERONE; PROTEIN KINASE C-ALPHA; PROTEIN KINASE INHIBITORS;

EID: 84939479182     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00532.2014     Document Type: Article

References (36)

1. 2 on proliferative cells. Neoplasia 5: 417–426, 2003.
2. Chataigneau T, Zerr M, Chataigneau M, Hudlett F, Hirn C, Pernot F, Schini-Kerth VB. Chronic treatment with progesterone but not medroxyprogesteroneacetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats. Menopause 11: 225–263, 2004.
3. Chen F, Yo Y, Haigh J, Jhonson S, Lucas R, Stepp D, Futton DJR. Regulation of NADPH oxidase 5 by protein kinase C isoforms. Plos One 9: e88405, 2014.
4. Cox MW, Weiping F, Chai H, Paladugu R, Lin PH, Lumsden AB, Yao Q, Chen C. Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J Surg Res 124: 104–111, 2005.
5. Duckles SP, Miller VM. Hormonal modulation of endothelial NO production. Pflugers Arch 459: 841–851, 2010.
6. Flores C, Rojas S, Aguayo C, Parodi J, Mann G, Pearson JD, Casanello P, Sobrevia L. Rapid stimulation of L-arginine transport by D-glucose involves p42/44(mapk) and nitric oxide in human umbilical vein endothelium. Circ Res 92: 64–72, 2003.
7. Furchgott RF, Zawadzki AJV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscles by acetylcholine. Nature 288: 373–376, 1980.
8. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, Ganz P, Creager MA. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 98: 1158–1163, 1998.
9. González M, Flores C, Pearson JD, Casanello P, Sobrevia L. Cell signalling-mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells. Pflugers Arch 448: 383–394, 2004.
10. Grupper A, Shashar M, Bahry D, Pri-Paz Y, Bentur O, Levi S, Chernichovski T, Chernin G, Schwartz IF. Cyclosporine attenuates arginine transport, in human endothelial cells, through modulation of cationic amino acid transporter-1. Am J Nephrol 37: 613–619, 2013.
11. Hayashi T, Ishikawa T, Yamada K, Kuzuya M, Naito M, Hidaka H, Iguchi A. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca(2)- calmodulin dependent mechanism. Biochem Biophys Res Commun 203: 1013–1019, 1994.
12. Ingbir M, Schwartz IF, Reshef R, Shtabsky A, Chernichovski T, Isserlin BA, Chernin G, Levo Y, Schwartz IF. Rosiglitazone attenuates aortic arginine transport, through inhibition of PKCα, in uremic rats. Am J Physiol Renal Physiol 295: F471–F477, 2008.
13. Kim-Schulze S, Lowe WL Jr, Schnaper HW. Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor. Circulation 98: 413–421, 1998.
14. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 280: 7460–7468, 2005.
15. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111: 383–930, 1986.
16. Levine RL, Chen SJ, Durand J, Chen YF, Oparil S. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation 94: 2221–2227, 1994.
17. Lovren F, Pan Y, Shukla PC, Quan A, Teoh H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. Am J Physiol Endocrinol Metab 296: E1440–E1449, 2009.
18. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitricoxide synthase may explain the “arginine paradox.” J Biol Chem 272: 31213–31216, 1997.
19. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, Krause DN. Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels, effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33: 1685–1691, 2002.
20. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol Regul Integr Comp Physiol 261: R1022–R1027, 1991.
21. Mineo C, Ying YS, Chapline C, Jaken S, Anderson RG. Targeting of protein kinase C alpha to caveola. J Biol Chem 141: 601–610, 1998.
22. Nesher N, Frolkis I, Schwartz D, Chernichovski T, Levi S, Pri-Paz Y, Chernin G, Shtabsky A, Ben-Gal Y, Paz Y, Schwartz IF. L-Arginine improves endothelial function, independently of arginine uptake, in aortas from chronic renal failure female rats. Am J Physiol Renal Physiol 306: F449–F456, 2014.
23. O’Riordan E, Chen J, Brodsky SV, Smirnova I, Li H, Goligorsky MS. Endothelial cell dysfunction: the syndrome in making. Kidney Int 67: 1654–1658, 2005.
24. Reshef R, Schwartz D, Ingbir M, Shtabsky A, Chernichovski T, Isserlin BA, Chernin G, Levo Y, Schwartz IF. A profound decrease in maternal arginine uptake provokes endothelial nitration in the pregnant rat. Am J Physiol Heart Circ Physiol 294: H1156–H1163, 2008.
25. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97: 5930–5935, 2000.
26. Schwartz D, Schwartz IF, Gnessin E, Wollman Y, Chernichovsky T, Blum M, Iaina A. Differential regulation of the glomerular arginine transporters (CAT-1 and CAT-2) in lipopolysaccharide treated rats. Am J Physiol Renal Physiol 284: F788–F795, 2003.
27. Schwartz IF, Ayalon R, Chernichovski T, Reshef R, Chernin G, Weinstein T, Litvak A, Levo Y, Schwartz D. Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats. Kidney Int 69: 298–303, 2006.
28. Schwartz IF, Chernichovski T, Krishtol N, Grupper A, Laron I, Schwartz D. Sexual dimorphism in glomerular arginine transport affects nitric oxide generation in old male rats. Am J Physiol Renal Physiol 297: F80–F84, 2009.
29. Schwartz IF, Chernichovski T, Schwartz D. Aortic arginine transport is attenuated, through post-translational modulation of CAT-1 by PKCalpha, in old male rats. Vasc Med 15: 55–59, 2010.
30. Schwartz IF, Grupper A, Soetendorp H, Hillel O, Laron I, Chernichovski T, Ingbir M, Shtabski A, Weinstein T, Chernin G, Shashar M, Hershkoviz R, Schwartz D. Attenuated glomerular arginine transport prevents hyperfiltration and induces HIF-1α in the pregnant uremic rat. Am J Physiol Renal Physiol 303: F396–F404, 2012.
31. Schwartz IF, Ingbir M, Chernichovski T, Reshef R, Chernin G, Litvak A, Weinstein T, Levo Y, Schwartz D. Arginine uptake is attenuated through post translational regulation of cationic amino-acid transporter-1, in hyperlipidemic rats. Atherosclerosis 194: 357–363, 2007.
32. Vásquez R, Farías M, Vega JL, Martin RS, Vecchiola A, Casanello P, Sobrevia L. D-Glucose stimulation of L-arginine transport and nitric oxide synthesis results from activation of mitogen-activated protein kinases p42/44 and Smad2 requiring functional type II TGF-beta receptors in human umbilical vein endothelium. J Cell Physiol 212: 626–632, 2007.
33. Virdis A, Taddei S. Endothelial aging and gender. Maturitas 71: 326–330, 2012.
34. Voss AK, Fortune JE. Estradiol-17β has a biphasic effect on oxytocin secretion by bovine granulose cells. Biol Reprod 48: 1404–1409, 1993.
35. Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation 104: 1773–1778, 2001.
36. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, Mann GE. Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16: 1584–1594, 2002.